Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1012
Gene Symbol: CDH13
CDH13
0.020 Biomarker disease BEFREE Cadherin-13 (CDH13), a member of the calcium-dependent cell adhesion molecule family, has been linked to neurodevelopmental disorders, including autism spectrum (ASD) and attention-deficit/hyperactivity (ADHD) disorders, but also to depression. 30165120 2019
Entrez Id: 1012
Gene Symbol: CDH13
CDH13
0.020 AlteredExpression disease BEFREE Dysregulation of CDH13 expression may thus contribute to alterations in this system of neurotransmission, impacting cognitive function, which is frequently impaired in neurodevelopmental disorders including attention-deficit/hyperactivity and autism spectrum disorders. 29018333 2017
Entrez Id: 285195
Gene Symbol: SLC9A9
SLC9A9
0.010 Biomarker disease BEFREE Interestingly, recent human genetic studies have implicated the endosomal Na<sup>+</sup>/H<sup>+</sup> exchanger NHE9 in both autism spectrum disorders (ASD) and attention deficit hyperactivity disorder (ADHD). 29362376 2018
Entrez Id: 2908
Gene Symbol: NR3C1
NR3C1
0.010 Biomarker disease BEFREE Nr3C1-Bhlhb2 Axis Dysregulation Is Involved in the Development of Attention Deficit Hyperactivity. 26820676 2017
Entrez Id: 8553
Gene Symbol: BHLHE40
BHLHE40
0.010 Biomarker disease BEFREE Nr3C1-Bhlhb2 Axis Dysregulation Is Involved in the Development of Attention Deficit Hyperactivity. 26820676 2017
Entrez Id: 590
Gene Symbol: BCHE
BCHE
0.010 GeneticVariation disease BEFREE Acetylcholine-metabolizing butyrylcholinesterase (BCHE) copy number and single nucleotide polymorphisms and their role in attention-deficit/hyperactivity syndrome. 24041656 2013
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.010 GeneticVariation disease BEFREE In a general population sample of 575 Italian pre-adolescents aged 10-14, we examined the association of the functional Val158Met COMT polymorphism and SES-both as linear and interactive effects-with oppositional defiant problems, conduct problems, and attention deficit/hyperactivity problems, as defined by the newly established Child Behaviour Check-List/6-18 DSM oriented scales. 19946720 2010
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.010 GeneticVariation disease BEFREE Variations in solute carrier family 6A, member 3 (SLC6A3/DAT1), the human gene encoding DAT, have been implicated in attention deficit hyperactivity and bipolar disorders, and DAT is a prominent site of action for drugs such as amphetamines and cocaine.In this issue of the JCI, Kurian et al. report that an autosomal recessive infantile parkinsonism-dystonia is caused by loss-of-function mutations in DAT that impair dopamine reuptake (see the related article beginning on page 1595). 19504720 2009
Entrez Id: 3351
Gene Symbol: HTR1B
HTR1B
0.010 Biomarker disease BEFREE The objectives of this study were to: (i) expand our original investigation of the relationship between the HTR1B receptor gene and attention deficit/hyperactivity and; (ii) to investigate a possible association of obsessive behaviors/perfectionism and the HTR1B gene in a sample of 203 families with an ADHD proband. 16958036 2007
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.010 Biomarker disease BEFREE We genotyped ten single nucleotide polymorphisms (SNPs) in and around BDNF in 229 families and evaluate whether there are SNP-by-socioeconomic status (SES) interactions for attention deficit hyperactivity. 17216343 2007